Other studies have also indicated that single MCL‐1 siRNA delivery[198] or combined administration with DEXA[199] organized chondrocyte alignment, reduced inflammatory cell infiltration and significantly alleviated symptoms such as joint swelling, erythema and soft tissue edema. Here, MCL1 is linked to Erythema.